Dan A. Rock

2.7k total citations
68 papers, 2.1k citations indexed

About

Dan A. Rock is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Dan A. Rock has authored 68 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 30 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Dan A. Rock's work include Pharmacogenetics and Drug Metabolism (33 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Drug Transport and Resistance Mechanisms (16 papers). Dan A. Rock is often cited by papers focused on Pharmacogenetics and Drug Metabolism (33 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Drug Transport and Resistance Mechanisms (16 papers). Dan A. Rock collaborates with scholars based in United States, Germany and United Kingdom. Dan A. Rock's co-authors include Larry C. Wienkers, Jan L. Wahlstrom, Jeffrey P. Jones, R. Foti, Josh T. Pearson, Brooke M. Rock, Denise A. Rock, Leslie J. Dickmann, Sonal Patel and J. Greg Slatter and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

Dan A. Rock

68 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan A. Rock United States 28 953 721 633 359 264 68 2.1k
Ute M. Kent United States 26 1.1k 1.2× 454 0.6× 658 1.0× 132 0.4× 198 0.8× 59 2.0k
Fred K. Friedman United States 27 979 1.0× 744 1.0× 1.3k 2.1× 165 0.5× 211 0.8× 121 2.5k
S. Cyrus Khojasteh United States 24 617 0.6× 609 0.8× 627 1.0× 260 0.7× 191 0.7× 94 1.6k
Masato Chiba Japan 35 1.2k 1.2× 1.7k 2.3× 1.1k 1.7× 114 0.3× 213 0.8× 114 3.7k
Jason K. Yano United States 20 1.9k 2.0× 1.0k 1.4× 1.6k 2.5× 164 0.5× 1.1k 4.2× 29 3.6k
Cuyue Tang United States 25 839 0.9× 627 0.9× 631 1.0× 60 0.2× 206 0.8× 66 2.2k
Liang‐Shang Gan United States 25 759 0.8× 953 1.3× 843 1.3× 91 0.3× 223 0.8× 43 2.4k
Emre M. Isin United States 18 897 0.9× 328 0.5× 647 1.0× 51 0.1× 272 1.0× 38 1.8k
David D. Christ United States 25 472 0.5× 335 0.5× 537 0.8× 88 0.2× 129 0.5× 49 1.9k
Susan Hurst United States 18 937 1.0× 587 0.8× 439 0.7× 73 0.2× 241 0.9× 32 1.7k

Countries citing papers authored by Dan A. Rock

Since Specialization
Citations

This map shows the geographic impact of Dan A. Rock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan A. Rock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan A. Rock more than expected).

Fields of papers citing papers by Dan A. Rock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan A. Rock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan A. Rock. The network helps show where Dan A. Rock may publish in the future.

Co-authorship network of co-authors of Dan A. Rock

This figure shows the co-authorship network connecting the top 25 collaborators of Dan A. Rock. A scholar is included among the top collaborators of Dan A. Rock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan A. Rock. Dan A. Rock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Xue, Jianxia Shi, Hao Chen, et al.. (2024). Deciphering the Exact Sequence of Endogenous Soluble B Cell Maturation Antigen and Unbiased Quantitation in Multiple Myeloma Patient Samples by LC-MS. Clinical Chemistry. 70(1). 339–349. 1 indexed citations
2.
Finger, Elizabeth, Jamie Wong, Julia Gray, et al.. (2017). Utilization of Metabolomics to Identify Biomarkers in Hematological Malignancies: Role of IDO and the Tryptophan Pathway. Blood. 130. 5100–5100. 4 indexed citations
3.
Lorenczewski, Grit, Matthias Friedrich, Roman Kischel, et al.. (2017). Generation of a Half-Life Extended Anti-CD19 BiTE® Antibody Construct Compatible with Once-Weekly Dosing for Treatment of CD19-Positive Malignancies. Blood. 130. 2815–2815. 22 indexed citations
4.
Tibbitts, Jay, et al.. (2017). Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1. The AAPS Journal. 19(6). 1715–1734. 26 indexed citations
5.
Hamblett, Kevin J., Allison P. Jacob, Jesse L. Gurgel, et al.. (2015). SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm. Cancer Research. 75(24). 5329–5340. 90 indexed citations
6.
Eksterowicz, John, Dan A. Rock, Brooke M. Rock, Larry C. Wienkers, & R. Foti. (2014). Characterization of the Active Site Properties of CYP4F12. Drug Metabolism and Disposition. 42(10). 1698–1707. 16 indexed citations
7.
Rock, Brooke M., Shawna Hengel, Dan A. Rock, Larry C. Wienkers, & Kent L. Kunze. (2014). Characterization of Ritonavir-Mediated Inactivation of Cytochrome P450 3A4. Molecular Pharmacology. 86(6). 665–674. 71 indexed citations
8.
Conner, Kip P., Brooke M. Rock, Joseph P. Balthasar, et al.. (2014). Evaluation of Near Infrared Fluorescent Labeling of Monoclonal Antibodies as a Tool for Tissue Distribution. Drug Metabolism and Disposition. 42(11). 1906–1913. 42 indexed citations
9.
Foti, R., Josh T. Pearson, Julie Zalikowski, et al.. (2012). Predicting the Drug Interaction Potential of AMG 853, a Dual Antagonist of the D-Prostanoid and Chemoattractant Receptor-Homologous Molecule Expressed on T Helper 2 Cells Receptors. Drug Metabolism and Disposition. 40(12). 2239–2249. 2 indexed citations
10.
Davis, John A., Dan A. Rock, Larry C. Wienkers, & Josh T. Pearson. (2012). In Vitro Characterization of the Drug-Drug Interaction Potential of Catabolites of Antibody-Maytansinoid Conjugates. Drug Metabolism and Disposition. 40(10). 1927–1934. 25 indexed citations
11.
VandenBrink, Brooke M., R. Foti, Dan A. Rock, Larry C. Wienkers, & Jan L. Wahlstrom. (2011). Prediction of CYP2D6 Drug Interactions from In Vitro Data: Evidence for Substrate-Dependent Inhibition. Drug Metabolism and Disposition. 40(1). 47–53. 62 indexed citations
12.
Foti, R., Dan A. Rock, Josh T. Pearson, Jan L. Wahlstrom, & Larry C. Wienkers. (2011). Mechanism-Based Inactivation of Cytochrome P450 3A4 by Mibefradil through Heme Destruction. Drug Metabolism and Disposition. 39(7). 1188–1195. 34 indexed citations
13.
Foti, R., Dan A. Rock, Larry C. Wienkers, & Jan L. Wahlstrom. (2010). Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation. Drug Metabolism and Disposition. 38(6). 981–987. 103 indexed citations
14.
Cho, Kyung‐Bin, Yohann Moreau, Devesh Kumar, et al.. (2007). Formation of the Active Species of Cytochrome P450 by Using Iodosylbenzene: A Case for Spin‐Selective Reactivity. Chemistry - A European Journal. 13(14). 4103–4115. 42 indexed citations
15.
Kumar, Vikas, et al.. (2006). CYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition Profiles. Drug Metabolism and Disposition. 34(12). 1966–1975. 95 indexed citations
16.
Hummel, Matthew, Timothy S. Tracy, J. Matthew Hutzler, et al.. (2006). Influence of Fluorescent Probe Size and Cytochrome b5 on Drug-Drug Interactions in CYP2C9. SLAS DISCOVERY. 11(3). 303–309. 6 indexed citations
17.
Hummel, Matthew A., Charles W. Locuson, Peter M. Gannett, et al.. (2005). CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions: Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 Variant. Molecular Pharmacology. 68(3). 644–651. 39 indexed citations
18.
Rock, Dan A., et al.. (2004). AN ANALYSIS OF THE REGIOSELECTIVITY OF AROMATIC HYDROXYLATION AND N-OXYGENATION BY CYTOCHROME P450 ENZYMES. Drug Metabolism and Disposition. 32(3). 328–332. 33 indexed citations
19.
French, Kevin J., Dan A. Rock, Denise A. Rock, et al.. (2002). Active Site Mutations of Cytochrome P450cam Alter the Binding, Coupling, and Oxidation of the Foreign Substrates (R)- and (S)-2-Ethylhexanol. Archives of Biochemistry and Biophysics. 398(2). 188–197. 19 indexed citations
20.
Rock, Dan A., Anthony E. Boitano, Jan L. Wahlstrom, Denise A. Rock, & Jeffrey P. Jones. (2002). Use of Kinetic Isotope Effects to Delineate the Role of Phenylalanine 87 in P450BM-3. Bioorganic Chemistry. 30(2). 107–118. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ute M. Kent Breakdown of academic impact, for papers by Fred K. Friedman Breakdown of academic impact, for papers by S. Cyrus Khojasteh Breakdown of academic impact, for papers by Masato Chiba Breakdown of academic impact, for papers by Jason K. Yano Breakdown of academic impact, for papers by Cuyue Tang Breakdown of academic impact, for papers by Liang‐Shang Gan Breakdown of academic impact, for papers by Emre M. Isin Breakdown of academic impact, for papers by David D. Christ Breakdown of academic impact, for papers by Susan Hurst
Rankless by CCL
2026